AtriCure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AtriCure and other ETFs, options, and stocks.

About ATRC

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. 

CEO
Michael H. Carrel
CEOMichael H. Carrel
Employees
1,300
Employees1,300
Headquarters
Mason, Ohio
HeadquartersMason, Ohio
Founded
1994
Founded1994
Employees
1,300
Employees1,300

ATRC Key Statistics

Market cap
1.67B
Market cap1.67B
Price-Earnings ratio
-62.27
Price-Earnings ratio-62.27
Dividend yield
Dividend yield
Average volume
458.25K
Average volume458.25K
High today
$34.31
High today$34.31
Low today
$30.47
Low today$30.47
Open price
$34.05
Open price$34.05
Volume
1.80M
Volume1.80M
52 Week high
$43.18
52 Week high$43.18
52 Week low
$28.29
52 Week low$28.29

Stock Snapshot

The current AtriCure(ATRC) stock price is $32.95, with a market capitalization of 1.67B. The stock trades at a price-to-earnings (P/E) ratio of -62.27.

On 2026-02-11, AtriCure(ATRC) stock moved within a range of $30.47 to $34.31. With shares now at $32.95, the stock is trading +8.1% above its intraday low and -3.9% below the session's peak.

Trading volume for AtriCure(ATRC) stock has reached 1.8M, versus its average volume of 458.25K.

The stock's 52-week range extends from a low of $28.29 to a high of $43.18.

The stock's 52-week range extends from a low of $28.29 to a high of $43.18.

ATRC News

Simply Wall St 6d
Assessing AtriCure Valuation After Mixed Share Performance And Clinical Trial Progress

AtriCure (ATRC) has drawn investor attention after a period of mixed share performance, with a loss of 9.18% over the past month but a 16.83% gain in the past 3...

Assessing AtriCure Valuation After Mixed Share Performance And Clinical Trial Progress

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own ATRC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.